pennews
www.pennews.net
Dr Reddy’s Lab announces launch of Ramelteon Tablets
Business

Dr Reddy’s Lab announces launch of Ramelteon Tablets

Agency News

Hyderabad, Jul 23 : Dr Reddy’s Laboratories Limited along with its subsidiaries together on Tuesday announced the launch of Ramelteon Tablets, 8 mg, a therapeutically equivalent generic version of Rozerem (ramelteon, 8 mg) Tablets, approved by the US Food and Drug Administration (USFDA).

The Rozerem brand had US sales of approximately USD 91.3 million MAT for the most recent twelve months ending in May 2019 according to IQVIA Health, a company statement here said.

Dr Reddy’s Ramelteon Tablets, are available as 8 mg tablets in bottle count sizes of 30, 100, and 1000, the statement added. (UNI)